知镜 Cognispect · 医学文献与研究工作台

Engineered probiotics couple photothermal cuproptosis with biomechanical disruption and immune activation

Zhang X, Liu X, Huang K, et al.
Bioact Mater · 2026-09-21 · PMID 42828102

文献摘要

Living bacterial therapeutics face limitations from poor surface functionalization and a hostile tumor microenvironment. Here, we engineer EPACS (EcN@PDA/Au-CuS) by coating E. coli Nissle 1917 with polydopamine, which acts as an adhesive interfacial platform to direct the uniform in situ growth of Au-CuS heterojunctions across the bacterial surface. EPACS combines tumor colonization, high photothermal conversion, and stimuli-responsive Cu 2+ release for combined cuproptosis-mediated photothermal therapy. Mechanistically, EPACS induces oxidative stress and mitochondrial dysfunction, triggering both cuproptosis and apoptosis, while atomic force microscopy (AFM) reveals dynamic biomechanical changes-an initial RhoA/F-actin-dependent cellular stiffening that is subsequently reversed by laser irradiation into irreversible cytoskeletal disruption and enhanced cell killing. In vivo , EPACS achieves effective tumor accumulation and photothermal heating, resulting in substantial tumor suppression with favorable biosafety. When combined with laser irradiation, EPACS reduces collagen deposition and α-SMA expression, indicating stromal remodeling, and AFM confirms photothermal disruption of tumor matrix mechanics. This biomechanical remodeling is accompanied by immune modulation-decreased M2-like macrophages and regulatory T cells-suggesting enhanced antitumor immunity. Overall, EPACS integrates biochemical damage, cuproptosis/apoptosis, biomechanical regulation, and immunomodulation, offering a promising combined cancer therapy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。